# Effect of Semaglutide in Patients With Psoriasis and Obesity

> **NCT06937060** · PHASE3 · RECRUITING · sponsor: **The University of Hong Kong** · enrollment: 14 (estimated)

## Conditions studied

- Psoriasis (PsO)
- Obesity and Overweight

## Interventions

- **BIOLOGICAL:** semaglutide

## Key facts

- **NCT ID:** NCT06937060
- **Lead sponsor:** The University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-20
- **Primary completion:** 2026-07-31
- **Final completion:** 2027-01-31
- **Target enrollment:** 14 (ESTIMATED)
- **Last updated:** 2025-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06937060

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06937060, "Effect of Semaglutide in Patients With Psoriasis and Obesity". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06937060. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*